CABA (STOCKS)
Cabaletta Bio, Inc. Common Stock
$2.570000
-0.030000 (-1.15%)
Prev close: $2.600000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Steven Nichtberger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $256.77M
- Employees
- 167
- P/E (TTM)
- -1.02
- P/B (TTM)
- 1.79
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $163.42M |
| Research and Development | $132.01M |
| Other Operating Expenses | $31.40M |
| Operating Income/Loss | -$163.42M |
| Income/Loss From Continuing Operations After Tax | -$158.52M |
| Income/Loss From Continuing Operations Before Tax | -$158.52M |
| Interest Expense, Operating | $2.20M |
| Net Income/Loss | -$158.52M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$158.52M |
| Net Income/Loss Available To Common Stockholders, Basic | -$158.52M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.40 |
| Diluted Earnings Per Share | -$2.40 |
| Assets | $189.76M |
| Current Assets | $164.56M |
| Cash | $159.93M |
| Other Current Assets | $4.63M |
| Noncurrent Assets | $25.20M |
| Fixed Assets | $2.06M |
| Other Non-current Assets | $23.14M |
| Liabilities | $50.29M |
| Current Liabilities | $45.74M |
| Accounts Payable | $8.27M |
| Wages | $6.76M |
| Other Current Liabilities | $30.70M |
| Noncurrent Liabilities | $4.56M |
| Equity | $139.47M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $139.47M |
| Liabilities And Equity | $189.76M |
| Net Cash Flow From Operating Activities | -$118.86M |
| Net Cash Flow From Operating Activities, Continuing | -$118.86M |
| Net Cash Flow From Investing Activities | -$87.94M |
| Net Cash Flow From Investing Activities, Continuing | -$87.94M |
| Net Cash Flow From Financing Activities | $96.39M |
| Net Cash Flow From Financing Activities, Continuing | $96.39M |
| Exchange Gains/Losses | $7.00K |
| Net Cash Flow | -$110.40M |
| Net Cash Flow, Continuing | -$110.41M |
| Comprehensive Income/Loss | -$158.50M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$158.50M |
| Other Comprehensive Income/Loss | -$44.85M |